Clinical Trials Browser

Phase 3 × Completed × Vascular Diseases × Clear all

NCT00773747 2021-04-30

Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT00000479 2012-06-15

WHS

Phase 3 Completed

39,876 enrolled 11 charts

Cardiovascular Diseases, Cerebrovascular Disorders, Coronary Disease, Heart Diseases, Myocardial Infarction, Vascular Diseases, Myocardial Ischemia